PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806,000 | -19.7% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,004,000 | -24.0% | 620,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $1,321,000 | -42.4% | 620,000 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,294,000 | +397.6% | 620,000 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $461,000 | -4.4% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $482,000 | -14.1% | 620,000 | 0.0% | 0.00% | – |
| Q1 2022 | $561,000 | -88.7% | 620,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $4,966,000 | -4.3% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,189,000 | +24.2% | 620,000 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $4,179,000 | +2.0% | 620,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $4,098,000 | +45433.3% | 620,000 | +21279.3% | 0.01% | – |
| Q4 2017 | $9,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |